Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effect of Fasting Recommendations Among Patients Using GLP-1 Receptor Agonists — Stella

Home/Residual Gastric Contents/Effect of Fasting Recommendations Among Patients Using GLP-1 Receptor Agonists

View on ClinicalTrials.gov

Recruiting

Back to Residual Gastric Contents trials

Effect of Fasting Recommendations Among Patients Using GLP-1 Receptor Agonists

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Australia

Melbourne Gastro Oesophageal Surgery (MGOS), Melbourne, Victoria

St Vincent's Hospital Melbourne, Melbourne, Victoria

Key details

Sponsor

St Vincent's Hospital Melbourne

Enrollment target

~154 participants

Started

June 2025

Primary completion

February 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.